We are live on
!
Find out more
Canada Life Portfolio holdings
AUM
$55.8B
1-Year Est. Return
26.04%
This Fund
S&P 500
This Quarter
Est. Return
+12.79%
1 Year Est. Return
+26.04%
3 Year Est. Return
+87.85%
5 Year Est. Return
+117.08%
10 Year Est. Return
+382.61%
AUM
$45.5B
AUM Growth
+$3.87B
(+9.3%)
Cap. Flow
-$3.11B
Cap. Flow
% of AUM
-6.83%
Top 10 Holdings %
Top 10 Hldgs %
22.97%
Holding
2,251
New
17
Increased
879
Reduced
1,035
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$59.4M |
| 2 |
Amazon
AMZN
|
+$52.3M |
| 3 |
CRH
CRH
|
+$29.3M |
| 4 |
Kenvue
KVUE
|
+$28.9M |
| 5 |
Mastercard
MA
|
+$27.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$968M |
| 2 |
NetEase
NTES
|
+$689M |
| 3 |
Ryanair
RYAAY
|
+$518M |
| 4 |
Pinduoduo
PDD
|
+$419M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$59.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.06% |
| 2 | Financials | 12.85% |
| 3 | Healthcare | 12.76% |
| 4 | Consumer Discretionary | 11.54% |
| 5 | Communication Services | 7.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Madrigal Pharmaceuticals
MDGL
$11.9B
| $226K | ﹤0.01% |
982
-221
| -18% | -$38.7K |
|
1827
Melco Resorts & Entertainment
MLCO
$2.12B
| $226K | ﹤0.01% |
25,563
-85,489
| -77% | -$697K |
|
|
RDUS
1828
DELISTED
Radius Recycling
RDUS
| $225K | ﹤0.01% |
7,506
+3,278
| +78% | +$86.3K |
|
|
ALX
1829
Alexander's
ALX
$1.38B
| $222K | ﹤0.01% |
1,046
-1
| -0.1% | -$189 |
|
|
GOOD
1830
Gladstone Commercial Corp
GOOD
$618M
| $221K | ﹤0.01% |
16,805
-166
| -1% | -$2.08K |
|
|
TIXT
1831
DELISTED
TELUS International
TIXT
| $221K | ﹤0.01% |
25,821
-11,282
| -30% | -$82.1K |
|
|
PETQ
1832
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
| $220K | ﹤0.01% |
+11,185
| New | +$215K |
|
1833
Baytex Energy
BTE
$3.06B
| $219K | ﹤0.01% |
66,241
| – | – |
|
1834
Rhythm Pharmaceuticals
RYTM
$7.95B
| $219K | ﹤0.01% |
4,796
+1,249
| +35% | +$39.4K |
|
|
PRMW
1835
DELISTED
Primo Water Corporation
PRMW
| $219K | ﹤0.01% |
14,646
-1,231
| -8% | -$17.6K |
|
1836
Krystal Biotech
KRYS
$9.81B
| $213K | ﹤0.01% |
1,731
| – | – |
|
1837
TG Therapeutics
TGTX
$7.52B
| $212K | ﹤0.01% |
12,471
| – | – |
|
1838
Ginkgo Bioworks
DNA
$500M
| $210K | ﹤0.01% |
3,133
+240
| +8% | +$14.7K |
|
1839
Veracyte
VCYT
$3.72B
| $210K | ﹤0.01% |
7,668
-506
| -6% | -$12.2K |
|
1840
Ameresco
AMRC
$1.34B
| $207K | ﹤0.01% |
6,557
+219
| +3% | +$6.6K |
|
1841
Denali Therapeutics
DNLI
$4B
| $207K | ﹤0.01% |
9,724
| – | – |
|
1842
Beam Therapeutics
BEAM
$2.82B
| $200K | ﹤0.01% |
7,429
+1,039
| +16% | +$25.8K |
|
1843
BioNTech
BNTX
$23.3B
| $200K | ﹤0.01% |
1,908
-860
| -31% | -$86.7K |
|
1844
Peoples Bancorp
PEBO
$1.46B
| $200K | ﹤0.01% |
5,969
+216
| +4% | +$6.29K |
|
|
CBAY
1845
DELISTED
Cymabay Therapeutics
CBAY
| $198K | ﹤0.01% |
8,424
| – | – |
|
1846
JELD-WEN Holding
JELD
$162M
| $196K | ﹤0.01% |
10,426
+1,260
| +14% | +$18.7K |
|
1847
Mueller Water Products
MWA
$4.07B
| $196K | ﹤0.01% |
13,701
| – | – |
|
1848
Surgery Partners
SGRY
$2.09B
| $194K | ﹤0.01% |
6,094
| – | – |
|
|
HTLF
1849
DELISTED
Heartland Financial USA, Inc.
HTLF
| $193K | ﹤0.01% |
5,138
-2,635
| -34% | -$83.3K |
|
1850
Vermilion Energy
VET
$1.75B
| $189K | ﹤0.01% |
15,671
-8,193
| -34% | -$108K |
|
Similar funds
Canada Life's Q4 2023 Portfolio in Review
As of Q4 2023, Canada Life held 2,251 positions worth $45.5B, up 9.3% from $41.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Canada Life withdrew a net $3.11B in Q4 2023, closing 90 positions and reducing 1,035 holdings. Its most notable exit was Activision Blizzard, an estimated $59.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Canada Life opened a new position in Jazz Pharmaceuticals worth $9.89M.
- Canada Life's largest Q4 2023 buy was Jazz Pharmaceuticals: 80,654 shares worth $9.89M.
- Canada Life added most to AbbVie in Q4 2023, an estimated $59.4M increase.
- Canada Life's biggest Q4 2023 reduction was TSMC, cutting an estimated $968M.
- Canada Life fully exited Activision Blizzard in Q4 2023, selling an estimated $59.1M.
- Canada Life's ten largest holdings make up 23% of its $45.5B portfolio in Q4 2023.
- Canada Life opened 17 new positions and closed 90 in Q4 2023.
- Canada Life's portfolio value rose 9.3% quarter-over-quarter to $45.5B.
Based on Canada Life's 13F filing for Q4 2023, filed 13 Feb 2024.